US Broker Ratings

DENTSPLY SIRONA Inc. (XRAY) Stock Analysis: Insights into Its 13.39% Potential Upside

For investors seeking opportunities in the healthcare sector, DENTSPLY SIRONA Inc. (NASDAQ: XRAY) presents a compelling case with its diverse offerings in dental and healthcare consumables...

Alvotech (ALVO) Stock Analysis: Exploring a 101% Potential Upside in the Biosimilar Market

Alvotech (NASDAQ: ALVO), a Luxembourg-based biosimilar manufacturer, is capturing investor attention with its impressive 101.12% potential upside, as per analyst targets. With a market cap of..

LifeStance Health Group, Inc. (LFST) Stock Analysis: Exploring a 93.81% Potential Upside

LifeStance Health Group, Inc. (NASDAQ: LFST) has captured the attention of investors with its intriguing potential upside of 93.81%. As a pivotal player in the healthcare..

Envista Holdings Corporation (NVST) Stock Report: Navigating a -4.93% Potential Downside Amidst Mixed Analyst Ratings

Envista Holdings Corporation (NYSE: NVST), a prominent player in the healthcare sector specializing in dental products, presents a complex investment profile for potential investors. With a..

Warby Parker Inc. (WRBY) Investor Outlook: Navigating Strong Revenue Growth Amid Challenges

Warby Parker Inc. (NYSE: WRBY), a leading eyewear retailer headquartered in New York, has carved a niche in the healthcare sector, specifically within the medical instruments..

Protagonist Therapeutics, Inc. (PTGX) Stock Analysis: Strong Buy Ratings Signal a Promising 24.93% Upside Potential

Protagonist Therapeutics, Inc. (PTGX) has caught the attention of investors with its pronounced potential for growth within the biotechnology sector. Headquartered in Newark, California, this biopharmaceutical..

Merus N.V. (MRUS) Stock Analysis: Exploring a 62% Potential Upside in Innovative Oncology Solutions

Merus N.V. (NASDAQ: MRUS), a clinical-stage biotechnology company based in Utrecht, Netherlands, is capturing investor attention with its promising drug pipeline and significant potential upside, currently..

Zai Lab Limited (ZLAB): Investor Outlook on a Biotech Powerhouse with 58.58% Upside Potential

Zai Lab Limited (NASDAQ: ZLAB), a prominent player in the biotechnology sector, has been making waves in the healthcare industry with its innovative approach to tackling..

PROCEPT BioRobotics (PRCT) Stock Analysis: Unveiling a 32% Potential Upside in the Healthcare Sector

PROCEPT BioRobotics Corporation (NASDAQ: PRCT), a player in the burgeoning medical devices industry, is gaining significant attention from investors due to its innovative advancements in surgical..

Ultragenyx Pharmaceutical Inc. (RARE) Stock Analysis: A 207% Upside Potential Awaits Investors

Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) continues to capture the attention of investors with its promising pipeline and substantial growth potential. As a key player in the..

Viking Therapeutics, Inc. (VKTX) Investor Outlook: Assessing a Potential 185% Upside

Viking Therapeutics, Inc. (VKTX), a clinical-stage biopharmaceutical company based in San Diego, California, is capturing the attention of investors with its promising portfolio and significant growth..

Arcellx, Inc. (ACLX) Stock Analysis: A Promising 58.94% Upside in the Biotech Sector

Arcellx, Inc. (NASDAQ: ACLX) has caught the attention of investors with significant potential upside in the biotechnology sector. Focused on developing innovative immunotherapies for cancer and..

ICU Medical, Inc. (ICUI) Stock Analysis: Exploring a 42% Potential Upside with Strong Buy Ratings

ICU Medical, Inc. (NASDAQ: ICUI), a key player in the healthcare sector, is making waves in the medical instruments and supplies industry. With a market capitalization..

Krystal Biotech, Inc. (KRYS) Investor Outlook: Analyzing a 38.49% Upside Potential

Krystal Biotech, Inc. (NASDAQ: KRYS), a burgeoning player in the biotechnology sector, is capturing investor attention with a compelling upside potential of 38.49% based on current..

TransMedics Group, Inc. (TMDX) Stock Analysis: A 20.8% Potential Upside with Innovative Organ Care Solutions

TransMedics Group, Inc. (NASDAQ: TMDX) emerges as a formidable player in the healthcare sector, specifically within the medical devices industry. With a market capitalization of $3.8..

RadNet, Inc. (RDNT) Stock Analysis: A 29% Upside Potential with Strong Buy Ratings

RadNet, Inc. (NASDAQ: RDNT), a prominent player in the healthcare sector, is making waves in the diagnostics and research industry. With a market capitalization of $4.16..

Legend Biotech Corporation (LEGN) Stock Analysis: Exploring a 96% Potential Upside in Biotechnology

Legend Biotech Corporation (NASDAQ: LEGN) has emerged as a notable player in the biotechnology sector, captivating investor attention with its innovative approach to cancer treatment. Operating..

Oscar Health, Inc. (OSCR) Stock Analysis: Key Insights on a Healthcare Innovator with 21.65% Potential Upside

Oscar Health, Inc. (NYSE: OSCR) stands out as a dynamic player in the healthcare sector, specifically within the healthcare plans industry. With a market capitalization of..

Soleno Therapeutics, Inc. (SLNO) Stock Analysis: A Biotech with a 35.95% Potential Upside

Soleno Therapeutics, Inc. (NASDAQ: SLNO) is capturing the attention of investors with its promising potential upside of 35.95%. As a clinical-stage biopharmaceutical company based in Redwood..

Alkermes plc (ALKS) Stock Analysis: 35% Upside Potential and Strong Buy Ratings Boost Investor Outlook

Alkermes plc (ALKS), a prominent player in the healthcare sector, specializes in developing and commercializing pharmaceutical products tailored to address unmet medical needs. Headquartered in Dublin,..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds